Endosomal Transport of ErbB-2: Mechanism for Nuclear Entry of the Cell Surface Receptor
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The cell membrane receptor ErbB-2 migrates to the nucleus. However, the mechanism of its nuclear translocation is unclear. Here, we report a novel mechanism of its nuclear localization that involves interaction with the transport receptor importin beta1, nuclear pore protein Nup358, and a host of players in endocytic internalization. Knocking down importin beta1 using small interfering RNA oligonucleotides or inactivation of small GTPase Ran by RanQ69L, a dominant-negative mutant of Ran, causes a nuclear transport defect of ErbB-2. Mutation of a putative nuclear localization signal in ErbB-2 destroys its interaction with importin beta1 and arrests nuclear translocation, while inactivation of nuclear export receptor piles up ErbB-2 within the nucleus. Additionally, blocking of internalization by a dominant-negative mutant of dynamin halts its nuclear localization. Thus, the cell membrane-embedded ErbB-2, through endocytosis using the endocytic vesicle as a vehicle, importin beta1 as a driver and Nup358 as a traffic light, migrates from the cell surface to the nucleus. This novel mechanism explains how a receptor tyrosine kinase on the cell surface can be translocated into the nucleus. This pathway may serve as a general mechanism to allow direct communication between cell surface receptors and the nucleus, and our findings thus open a new era in understanding direct trafficking between the cell membrane and nucleus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Transport Between the Cell Nucleus and the Cytoplasm
Görlich, D., & Kutay, U. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.607 · Cited by 2,022
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Nucleocytoplasmic transport: the soluble phase
Mattaj, I. W., & Englmeier, L. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.265 · Cited by 1,175
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064 · cited 3×
“These nuclear RTKs have been shown to act as transcription factors (27, 36, 49, 54) for genes like Cyclin D1 (27), FGF2 (38), and COX-2 (49) and modulators for induction of c-jun and cyclin D1 (40).”
BackgroundSelf-citationKudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029 · cited 8×
“These data, together with ErbB-2–Crm1 interaction data (Fig.”
BackgroundInfluentialIdentification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962 · cited 1×
“In addition, when WT or NLS ErbB-2 was transfected into SKBr3 cells, treatment with heregulin (1, 18) reduced the level of ErbB-2 in the cell membrane and enhanced ErbB-2 cytoplasmic localization, suggesting that the ErbB-2 NLS mutant still undergoes normal internalization (Fig.”
MethodTransport into and out of the Nucleus
Macara, I. G. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.4.570-594.2001 · Cited by 905
γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase
Ni, C.-Y., Murphy, M. P., Golde, T. E., & Carpenter, G. (2001) · Science · doi:10.1126/science.1065412 · Cited by 856 · cited 2×
“These nuclear RTKs have been shown to act as transcription factors (27, 36, 49, 54) for genes like Cyclin D1 (27), FGF2 (38), and COX-2 (49) and modulators for induction of c-jun and cyclin D1 (40).”
BackgroundEstrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., & Osborne, C. K. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01961241 · Cited by 750 · cited 1×
“Interaction between ErbB-2 and importin 1 was detected in the cytoplasmic extracts of ErbB-2-overexpressing MDA-MB-453 and MCF-7/HER18 cells (4, 49) but not those of MCF-7 cells, which express basal levels of ErbB-2 (Fig.”
BackgroundRegulating Access to the Genome
Weis, K. (2003) · Cell · doi:10.1016/s0092-8674(03)00082-5 · Cited by 674
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594 · cited 1×
“Supporting this is the recently described ras signaling from different membrane compartments of the endoplasmic reticulum and Golgi complex (9) which is no longer limited to the plasma membrane, as it continues on the endomembrane.”
BackgroundNuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.007 · Cited by 544 · cited 1×
“More recently, the nuclear EGFR was shown to interact with well-known DNA binding transcriptional factors, such as STAT3 and E2F1, to regulate the expression of inducible nitric oxide synthase and B-Myb (17, 28).”
BackgroundSelf-citationNuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6
Freedman, D. A., & Levine, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7288 · Cited by 518 · cited 1×
“As a positive control, nuclear lysates from LMB-treated cells revealed elevated levels of other molecules, such as I B , cyclin B1, and MDM2, known to be arrested by such treatment (14, 19, 55).”
BackgroundA giant nucleopore protein that binds Ran/TC4
Yokoyama, N., Hayashi, N., Seki, T., Panté, N., Ohba, T., Nishii, K., Kuma, K., Hayashida, T., Miyata, T., Aebi, U., et al. (1995) · Nature · doi:10.1038/376184a0 · Cited by 498 · cited 5×
“The interaction between ErbB-2 and Nup358 suggests the involvement of NPC.”
BackgroundInfluentialWu, J., Matunis, M. J., Kraemer, D., Blobel, G., & Coutavas, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14209 · Cited by 480 · cited 5×
“The interaction between ErbB-2 and Nup358 suggests the involvement of NPC.”
BackgroundInfluentialSuntharalingam, M., & Wente, S. R. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00162-x · Cited by 410
Differential Distribution of Dynamin Isoforms in Mammalian Cells
Cao, H., Garcia, F., & McNiven, M. A. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.9.2595 · Cited by 402 · cited 1×
“GFP-tagged dynamin 2 (6), dominant-negative”
Huang, T. T., Kudo, N., Yoshida, M., & Miyamoto, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1014 · Cited by 380 · cited 1×
“As a positive control, nuclear lysates from LMB-treated cells revealed elevated levels of other molecules, such as I B , cyclin B1, and MDM2, known to be arrested by such treatment (14, 19, 55).”
BackgroundImportin β Is a Mitotic Target of the Small GTPase Ran in Spindle Assembly
Nachury, M. V., Maresca, T. J., Salmon, W. C., Waterman-Storer, C. M., Heald, R., & Weis, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00194-5 · Cited by 376
AP-2/Eps15 Interaction Is Required for Receptor-mediated Endocytosis
Benmerah, A., Lamaze, C., Bègue, B., Schmid, S. L., Dautry-Varsat, A., & Cerf-Bensussan, N. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1055 · Cited by 347 · cited 4×
“mutant K44A (7), and GFP-tagged EPS15 (3) were kindly provided by Mark A.”
MethodInfluentialControl of Cyclin B1 localization through regulated binding of the nuclear export factor CRM1
Yang, J., Bardes, E. S. G., Moore, J. D., Brennan, J., Powers, M. A., & Kornbluth, S. (1998) · Genes & Development · doi:10.1101/gad.12.14.2131 · Cited by 323 · cited 1×
“As a positive control, nuclear lysates from LMB-treated cells revealed elevated levels of other molecules, such as I B , cyclin B1, and MDM2, known to be arrested by such treatment (14, 19, 55).”
BackgroundBinding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
Wang, S.-C., Lien, H.-C., Xia, W., Chen, I.-F., Lo, H.-W., Wang, Z., Ali-Seyed, M., Lee, D.-F., Bartholomeusz, G., Ou-Yang, F., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.012 · Cited by 305 · cited 6×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundInfluentialSelf-citationNovel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer
Lo, H.-W., Xia, W., Wei, Y., Ali-Seyed, M., Huang, S.-F., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.338.65.1 · Cited by 290 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundSelf-citationImportin-beta-like nuclear transport receptors.
Ström, A.-C., & Weis, K. (2001) · Genome biology · doi:10.1186/gb-2001-2-6-reviews3008 · Cited by 279
Gradient of Increasing Affinity of Importin β for Nucleoporins along the Pathway of Nuclear Import
Ben-Efraim, I., & Gerace, L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.411 · Cited by 274 · cited 1×
“It has been reported that interaction between importin 1 and nuclear pore protein Nup358, a nucleoporin located at the cytoplasmic filaments of the nuclear pore complexes (NPC) (53, 56), plays a pivotal role in protein nuclear import (2).”
BackgroundImportin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor
Reilly, J. F., & Maher, P. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1307 · Cited by 231
Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2.
Maher, P. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.2.529 · Cited by 224 · cited 2×
“The cell surface ErbB-2 was labeled via biotinylation (31), a process that labels only cell surface molecules, and the nuclear extracts from these cells were analyzed for the biotinylated ErbB-2 to detect nuclear translocation of cell surface ErbB-2.”
BackgroundOffterdinger, M., Schöfer, C., Weipoltshammer, K., & Grunt, T. W. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109033 · Cited by 208
Feng, Y., Venema, V. J., Venema, R. C., Tsai, N., & Caldwell, R. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9790 · Cited by 208 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundSubcellular fractionation : a practical approach
Graham, J. M., & RICKWOOD, D. (1997) · Cited by 206
Nucleocytoplasmic transport: cargo trafficking across the border
Weis, K. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00337-x · Cited by 190
Co‐regulation of B‐Myb expression by E2F1 and EGF receptor
Hanada, N., Lo, H., Day, C., Pan, Y., Nakajima, Y., & Hung, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20147 · Cited by 188
Self-citationSignalling shortcuts: cell-surface receptors in the nucleus?
Wells, A. H., & Marti, U. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm905 · Cited by 172
Nuclear localization and possible functions of receptor tyrosine kinases
Carpenter, G. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00015-2 · Cited by 169
Jurata, L. W., Pfaff, S. L., & Gill, G. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3152 · Cited by 164
Cytoplasmic transport of Stat3 by receptor‐mediated endocytosis
Bild, A. H., Turkson, J., & Jove, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf351 · Cited by 160 · cited 1×
“also indicated that, following growth factor stimulation, STAT3 translocates from the cell membrane to the perinuclear region via endocytic vesicles, and this translocation is essential for STAT3-dependent gene regulation (5), supporting the notion that endocytic vesicles may function as a vehicle to carry cargo prote…”
BackgroundHyman, J., Chen, H., Di Fiore, P. P., De Camilli, P., & Brunger, A. T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.537 · Cited by 158 · cited 1×
“In addition, it has been reported that endocytic proteins, including EPS15, epsin 1, Eps15R, -adaptin, and the clathrin assembly lymphoid myeloid leukemia protein, shuttle in and out of the nucleus (10, 12, 20, 48).”
BackgroundSever, S. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00347-2 · Cited by 150
Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin
Thompson, H. C., Krueger, E. W., & McNiven, M. A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1993 · Cited by 136
Xie, Y., & Hung, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2368 · Cited by 134 · cited 2×
“These nuclear RTKs have been shown to act as transcription factors (27, 36, 49, 54) for genes like Cyclin D1 (27), FGF2 (38), and COX-2 (49) and modulators for induction of c-jun and cyclin D1 (40).”
BackgroundSelf-citationFibroblast Growth Factor Receptors (FGFRs) Localize in Different Cellular Compartments
Johnston, C. L., Cox, H. C., Gomm, J. J., & Coombes, R. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30643 · Cited by 133
Stachowiak, E. K., Maher, P. A., Tucholski, J., Mordechai, E., Joy, A. M., Moffett, J., Coons, S. W., & Stachowiak, M. K. (1997) · Oncogene · doi:10.1038/sj.onc.1201057 · Cited by 126 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundStachowiak, M. K., Maher, P. A., Joy, A. M., Mordechai, E., & Stachowiak, E. K. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.8.1299 · Cited by 115 · cited 2×
“Additionally, nuclear matrix binding of FGFR1 and insulin receptor (41, 45) has been shown to strategically position the receptors for involvement in the regulation of gene expression.”
BackgroundStachowiak, E. K., Fang, X., Myers, J., Dunham, S., & Stachowiak, M. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01624.x · Cited by 109 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundPeng, H., Moffett, J. R., Myers, J. M., Fang, X., Stachowiak, E. K., Maher, P. A., Kratz, E., Hines, J., Fluharty, S. J., Mizukoshi, E., et al. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.2.449 · Cited by 100 · cited 1×
“These nuclear RTKs have been shown to act as transcription factors (27, 36, 49, 54) for genes like Cyclin D1 (27), FGF2 (38), and COX-2 (49) and modulators for induction of c-jun and cyclin D1 (40).”
BackgroundNucleocytoplasmic Shuttling of Endocytic Proteins
Vecchi, M., Polo, S., Poupon, V., van de Loo, J.-W., Benmerah, A., & Di Fiore, P. P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1511 · Cited by 96 · cited 3×
“In addition, the nucleocytoplasmic shuttling of endocytic proteins is believed to play a role in transcription (48), but how these bona fide proteins of endocytosis enter the nucleus is unknown.”
BackgroundSubcellular Fractionation: A Practical Approach
(1997) · doi:10.1093/oso/9780199634958.001.0001 · Cited by 92
Mayo, L. D., Kessler, K. M., Pincheira, R., Warren, R. S., & Donner, D. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102932200 · Cited by 84 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundCoda, L., Salcini, A. E., Confalonieri, S., Pelicci, G., Sorkina, T., Sorkin, A., Pelicci, P. G., & Di Fiore, P. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3003 · Cited by 76 · cited 1×
“In addition, it has been reported that endocytic proteins, including EPS15, epsin 1, Eps15R, -adaptin, and the clathrin assembly lymphoid myeloid leukemia protein, shuttle in and out of the nucleus (10, 12, 20, 48).”
BackgroundNF-κB p65 transactivation domain is involved in the NF-κB-inducing kinase pathway
Jiang, X., Takahashi, N., Ando, K., Otsuka, T., Tetsuka, T., & Okamoto, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00011-1 · Cited by 67 · cited 1×
“Using Ikk (22) as a positive control (Fig.”
BackgroundAltered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer
Zammit, C., Barnard, R., Gomm, J. J., Coope, R., Shousha, S., Coombes, C., & Johnston, C. (2001) · Journal of Pathology · doi:10.1002/path.846 · Cited by 61 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundIlan, N., Tucker, A., & Madri, J. A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000083531.84403.8b · Cited by 58 · cited 1×
“However, some RTKs, like the epidermal growth factor receptor (EGFR) family members (27, 29, 32, 36, 37, 49, 54), fibroblast growth factor receptor 1 (FGFR1) and FGFR3 and their splice variants (23, 31, 40, 43, 44, 45, 57), insulin receptor (41), and vascular endothelium growth factor receptor Flk1/KDR (13, 21, 34), a…”
BackgroundDoria, M., Salcini, A. E., Colombo, E., Parslow, T. G., Pelicci, P. G., & Di Fiore, P. P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1379 · Cited by 45 · cited 1×
“In addition, it has been reported that endocytic proteins, including EPS15, epsin 1, Eps15R, -adaptin, and the clathrin assembly lymphoid myeloid leukemia protein, shuttle in and out of the nucleus (10, 12, 20, 48).”
BackgroundElk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase.
Rao, V. N., & Reddy, E. S. P. (1993) · PubMed · Cited by 27
Cited by
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A., & Goh, L. K. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 756
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
Metadata
- Authors
- Giri, D. K., Ali-Seyed, M., Li, L.-Y., Lee, D.-F., Ling, P., Bartholomeusz, G., Wang, S.-C., & Hung, M.-C.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2005-12-01
- Volume
- 25
- Issue
- 24
- Pages
- 11005-11018
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2139577140
- Cited by
- 244
- References
- 55
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.